| Aug 14 |
Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update
|
| Aug 13 |
Aethlon Medical Q1 2025 Earnings Preview
|
| Aug 13 |
Aethlon Medical receives ethics committee approval for trial of cancer treatment
|
| Aug 12 |
Aethlon Medical receives second ethics committee approval for Hemopurifier cancer trial
|
| Aug 12 |
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
|
| Aug 12 |
Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial
|
| Aug 6 |
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024
|
| Jul 8 |
AEMD: Approval from 1st Site, Submitting to Additional Sites for Oncology Trial
|
| Jun 28 |
Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript
|
| Jun 27 |
Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript
|
